Two Sigma Securities’s VIVEVE MED INC VIVE Stock Holding History

Two Sigma Securities’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,432	Closed	-$6.13K	–	3503
2022 Q4	$6.13K	Buy	14,432 +1,022	+8%	+$515	﹤0.01%	2435
2022 Q3	$9K	Sell	13,410 -1,853	-12%	-$1.39K	﹤0.01%	2424
2022 Q2	$10K	Buy	+15,263	New	+$13K	﹤0.01%	2059
2019 Q3	–	Sell	-14	Closed	-$5K	–	2569
2019 Q2	$5K	Buy	+14	New	+$7.59K	﹤0.01%	2029
2019 Q1	–	Sell	-12	Closed	-$12K	–	2588
2018 Q4	$12K	Buy	+12	New	+$28.8K	﹤0.01%	2005

Other funds holding VIVE

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Two Sigma Securities's VIVE Position: Q1 2023 in Review

Two Sigma Securities sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 14,432 shares — an estimated $6.13K sold.

Two Sigma Securities first reported a position in VIVE in Q4 2018 and held it in 5 quarters. The position peaked at $12K in Q4 2018. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.

Two Sigma Securities reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 14,432 VIVEVE MED INC shares in Q1 2023, an estimated $6.13K.
Two Sigma Securities first reported a position in VIVEVE MED INC in Q4 2018 and held it in 5 quarters.
Two Sigma Securities's VIVEVE MED INC position peaked at $12K in Q4 2018.
1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.